Concord Wealth Partners - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
Concord Wealth Partners ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$69,000
-54.3%
1,585
-54.2%
0.02%
-51.3%
Q1 2022$151,000
-2.6%
3,459
-1.7%
0.04%
+2.6%
Q4 2021$155,000
+496.2%
3,520
+412.4%
0.04%
+245.5%
Q3 2021$26,000
-76.1%
687
-75.0%
0.01%
-64.5%
Q2 2021$109,000
+62.7%
2,744
+47.2%
0.03%
+34.8%
Q1 2021$67,000
+131.0%
1,864
+134.5%
0.02%
+4.5%
Q4 2020$29,0007950.02%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2021
NameSharesValueWeighting ↓
Chubb Ltd 400,000$15,404,0006.76%
KAHN BROTHERS GROUP INC 833,315$32,090,960,0005.42%
Sio Capital Management, LLC 180,811$6,963,0004.06%
Sio Capital Management, LLC 170,000$6,547,0003.82%
OSTERWEIS CAPITAL MANAGEMENT INC 1,124,462$43,304,0003.12%
Keystone Financial Planning, Inc. 120,705$4,648,0003.04%
PVG Asset Management 186,553$7,184,156,0003.02%
P.R. Herzig & Co. Inc. 37,950$1,461,0002.98%
EQUITY INVESTMENT CORP 2,329,469$89,708,0002.89%
Sterneck Capital Management, LLC 114,816$4,422,0002.84%
View complete list of GLAXOSMITHKLINE PLC shareholders